PURCHASE, N.Y., March 30 /PRNewswire-FirstCall/ -- Nutrition 21 is pleased to announce that Michael A. Zeher, President and Chief Executive Officer, has been elected to the board of directors of the Consumer Healthcare Products Association (CHPA). CHPA is a 128-year old trade association representing manufacturers and distributors of over-the-counter medicines and nutritional supplement products. Members were elected at the association's March 14th Annual Executive Conference.
Headquartered in Washington, DC, CHPA, is a member-based organization which represents leading manufacturers and distributors of nonprescription, over-the-counter (OTC) medicines, and nutritional supplements. Mr. Zeher commented on his appointment, "I am very excited about again joining the CHPA board. This organization's long history of providing education and guidance on the responsible and safe use of nutritional supplements and OTC medicines could not be more timely or more relevant. With the nation's current economic environment and the challenges our healthcare system faces, consumers are increasingly turning toward the nutritional and OTC industries for more affordable and effective treatments. The role of the products that CHPA represents offer opportunities to both the consumer and governmental agencies that are looking for solutions to a more affordable healthcare approach."
Mr. Zeher joined Nutrition 21, Inc. as President and CEO in July, 2008. Mr. Zeher has vast experience in the consumer healthcare products industry, including 20 years at Johnson & Johnson in senior sales and marketing positions. Prior to joining Nutrition 21, he served as President-CEO of nutraceutical, dietary supplements, OTC and Health and Beauty Care manufacturing and marketing companies.
The Consumer Healthcare Products Association (CHPA), founded in 1881, is a member-based association representing the leading manufacturers and distributors of nonprescription, over-the-counter (OTC) medicines and nutritional supplements. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and nutritional supplements in America's healthcare system through science, education, and advocacy. The association provides leadership and guidance on regulatory and scientific issues to Congress; state legislatures; and federal, state, and international government agencies. CHPA shares tools and information with partners across the globe to ensure the safe and responsible use of OTC medicines. For more information please visit http://www.chpa-info.org.
About Nutrition 21
Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness products include: Iceland Health(R) Chromax(R), Iceland Health(R) Advanced Memory Formula(TM), Iceland Health(R) Omega-3 Fish Oil, Iceland Health(R) Joint Relief, and Diabetes Essentials(R). The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 30,000 major food, drug and super center stores throughout the United States, and internationally. For more information please visit http://www.nutrition21.com.
Company Contact: Investor Contact: Alan Kirschbaum Joe Diaz, Robert Blum, Joe Dorame Chief Financial Officer Lytham Partners, LLC (914) 701-4500 (602) 889-9700 email@example.com
|SOURCE Nutrition 21, Inc.|
Copyright©2009 PR Newswire.
All rights reserved